BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35830453)

  • 1. Identification of the shared gene signatures and pathways between polycystic ovary syndrome and endometrial cancer: An omics data based combined approach.
    Miao C; Chen Y; Fang X; Zhao Y; Wang R; Zhang Q
    PLoS One; 2022; 17(7):e0271380. PubMed ID: 35830453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
    Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
    Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
    Qiao G; Xing J; Luo X; Zhang C; Yi J
    Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of shared gene signatures and biological mechanisms between polycystic ovary syndrome and asthma: Based on weighted gene coexpression network analysis.
    Bai L; Gao X; Guo Y; Gong J; Li Y; Huang H; Liu X
    Int J Gynaecol Obstet; 2024 Apr; 165(1):155-168. PubMed ID: 38055328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Analysis of Core Genes and Biological Process Involved in Polycystic Ovary Syndrome.
    Zhang Y; Zhao T; Hu L; Xue J
    Reprod Sci; 2023 Oct; 30(10):3055-3070. PubMed ID: 37171773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of key genes and molecular pathways in type 2 diabetes mellitus and polycystic ovary syndrome via bioinformatics analyses.
    Zhang J; Zhang FJ; Zhang L; Xian DX; Wang SA; Peng M; Liu Y
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3255-3269. PubMed ID: 37140276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
    Bi X; Zhai Z; Wang S
    Gen Physiol Biophys; 2019 May; 38(3):205-214. PubMed ID: 31184307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
    Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
    Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): time for paradigm shift?
    Shafiee MN; Chapman C; Barrett D; Abu J; Atiomo W
    Gynecol Oncol; 2013 Nov; 131(2):489-92. PubMed ID: 23822891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas.
    Alqutami F; Hachim M; Hodgman C; Atiomo W
    Oncotarget; 2023 Sep; 14():825-835. PubMed ID: 37737665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data.
    Hou Y; Wang Y; Xu S; Qi G; Wu X
    Mol Med Rep; 2019 Jul; 20(1):281-291. PubMed ID: 31115532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landscape of PCOS co-expression gene and its role in predicting prognosis and assisting immunotherapy in endometrial cancer.
    Zhang Y; Hu Y; Yu J; Xie X; Jiang F; Wu C
    J Ovarian Res; 2023 Jul; 16(1):129. PubMed ID: 37393293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Crucial lncRNAs, miRNAs, mRNAs, and Potential Therapeutic Compounds for Polycystic Ovary Syndrome by Bioinformatics Analysis.
    Zeng Z; Lin X; Xia T; Liu W; Tian X; Li M
    Biomed Res Int; 2020; 2020():1817094. PubMed ID: 33224973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor‑microRNA synergistic regulatory network revealing the mechanism of polycystic ovary syndrome.
    Liu HY; Huang YL; Liu JQ; Huang Q
    Mol Med Rep; 2016 May; 13(5):3920-8. PubMed ID: 27035648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Analysis of ceRNA Network Related to Polycystic Ovarian Syndrome.
    Li Y; Tan Y
    Comput Math Methods Med; 2021; 2021():9988347. PubMed ID: 34211581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explore the potential molecular mechanism of polycystic ovarian syndrome by protein-protein interaction network analysis.
    Chen Q; Zheng B; Du S; Lin Y
    Taiwan J Obstet Gynecol; 2021 Sep; 60(5):807-815. PubMed ID: 34507653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
    Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
    Shen H; Liang Z; Zheng S; Li X
    Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks.
    Zhou W; Zhang T; Lian Y; Zhang W; Yang M; Li Y; Wang L; Yan X
    Reprod Biomed Online; 2022 May; 44(5):777-790. PubMed ID: 35337736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Potential Biomarkers of Polycystic Ovary Syndrome via Integrated Bioinformatics Analysis.
    Yang D; Li N; Ma A; Dai F; Zheng Y; Hu X; Wang Y; Xian S; Zhang L; Yuan M; Liu S; Deng Z; Yang Y; Cheng Y
    Reprod Sci; 2021 May; 28(5):1353-1361. PubMed ID: 33067753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.